Finally, a model combining age, gender, albumin–bilirubin, and platelets (i.e., aMAP score), specifically developed for the prediction of HCC development in patients with chronic hepatitis, showed accuracies from 0.68 to 0.77 in post-SVR cirrhotic patients [15]. The gene discussed is ALB; the disease is hepatocellular carcinoma.